Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

Clinical trial NCT04665206 · RECRUITING

Trial details

NCT number: NCT04665206
Sponsor: Vivace Therapeutics, Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Mesothelioma NSCLC

Start date: 2021-03-24
Primary completion: 2029-11-02
Enrollment: 434

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.